Synvisc

Synvisc

Manufacturer:

Genzyme

Distributor:

DKSH
Concise Prescribing Info
Contents
Hylan G-F 20
Indications/Uses
Temporary replacement & supplement for synovial fluid in all stages of joint pathology. Pain associated w/ knee, hip, ankle & shoulder OA.
Dosage/Direction for Use
IA inj Knee OA 3 inj 1 wk apart. Max: 6 inj w/in 6 mth w/ min of 4-wk interval. Hip, ankle, shoulder OA Initially 1 inj, 2nd inj may be administered after 1-3 mth.
Contraindications
Venous or lymphatic limb stasis, infected or severely inflamed joints, skin diseases or infections at inj site.
Special Precautions
Hypersensitivity to avian protein. Not to be inj extra-articularly, intravascularly or into synovial tissues & cap. Large IA effusion. Avoid strenuous activity following inj. Pregnancy. Childn <18 yr.
Adverse Reactions
Pain, swelling &/or effusion in injected joint.
ATC Classification
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
Presentation/Packing
Form
Synvisc inj 8 mg/mL
Packing/Price
2 mL x 3 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in